|
Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses
|
De Beuckelaer, A.; Pollard, C.; Van Lint, S.; Roose, K.; Van Hoecke, L.; Naessens, T.; Udhayakumar, V. K.; Smet, M.; Sanders, N.; Lienenklaus, S.; Saelens, X.; Weiss, S.; Vanham, G.; Grooten, J.; De Koker, S.
|
Molecular Therapy |
2016
|
Article
|
|
Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines
|
Pollard, C.; Rejman, J.; De Haes, W.; Verrier, B.; Van Gulck, E.; Naessens, T.; De Smedt, S.; Bogaert, P.; Grooten, J.; Vanham, G.; De Koker, S.
|
Molecular Therapy |
2013
|
Article
|